Clover 医疗
CLOV
4.48
-0.20
-4.27%
Clover 医疗
US · CLOV
#2665 按市值排名
上市于 1970
4.48
-0.20
-4.27%
实时 - 追踪5344个代码 - 心跳于336秒前
· 2026-10-16 19:50
✦ 量化股权信号 计算方式说明
增持
- 最近一期(2026/Q3)披露持股的机构数量增加了5家。
- 机构持股总比例上升了0.3个百分点。
机构持股
- 机构持股比例
- 28.23% +0.30pp
- 机构数量
- 260 +5
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向分歧机构在上一报告期增持了股份,同时该股在最近20个交易日的主力资金呈净流出——两者方向出现分歧。
机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。
持股人类型
Mutual Fund21.93%
Individual/Insider21.64%
Hedge Fund3.05%
Public Company1.57%
Private Company0.71%
Insurance Company0.62%
Government Pension Fund0.22%
Family Office/Trust0.11%
Other50.13%
主要股东 截至 2026-03-31
Vivek Garipalli
17.62% · 93.58M 股
BlackRock
6.61% · 35.12M 股
Vanguard Capital Management, LLC
3.95% · 20.96M 股
Geode Capital Management, LLC
2.04% · 10.85M 股
State Street Global Advisors
1.92% · 10.18M 股
Andrew Toy
1.22% · 6.50M 股
Teachers Insurance and Annuity Association-College Retirement Equities Fund
1.13% · 6.02M 股
Charles Schwab Investment Management
1.04% · 5.52M 股
Vanguard Portfolio Management, LLC
0.84% · 4.47M 股
Northern Trust Global Investments
0.71% · 3.77M 股
条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 4次买入 · 44次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Vivek Garipalli | Co-Founder & Executive Chairperson | 17.62% |
| Andrew Toy | Chief Executive Officer | 1.22% |
| Jamie Reynoso | Divisional Chief Executive Officer of Medicare Advantage | 0.53% |
| Conrad Wai | Chief Technology Officer | 0.42% |
| Brady Priest | Chief Executive Officer of Home Care | 0.38% |
| Karen Soares | Deputy General Counsel & Corporate Secretary | 0.30% |
| Peter Kuipers | Chief Financial Officer | 0.30% |
| Clay Thornton | Chief Financial Officer of Medicare Advantage Division | 0.24% |
| Chelsea Clinton | Independent Director | 0.10% |
| Lee Shapiro | Independent Director | 0.10% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-10-04 | Jamie Reynoso | Divisional Chief Executive Officer of Medicare Advantage | Open Market Disposition | -8,750 | $4.42 |
| 2026-09-30 | Andrew Toy | Chief Executive Officer | Open Market Disposition | -318,806 | $4.19 |
| 2026-09-29 | Robert Torricelli | Director | Other Acquisition | +12,481 | -- |
| 2026-09-29 | Brian Miller | Director | Other Acquisition | +12,481 | -- |
| 2026-09-23 | Brady Priest | Chief Executive Officer of Home Care | Intent to Sell (Form 144) | -141,418 | $4.46 |
| 2026-09-21 | Robert Torricelli | Director | Initial Statement of Beneficial | 0 | -- |
| 2026-09-16 | Jamie Reynoso | Divisional Chief Executive Officer of Medicare Advantage | Automatic Disposition | -1,921 | $4.56 |
| 2026-09-15 | Joseph Oldakowski | VP of Finance & Controller | Open Market Disposition | -3,170 | $4.64 |
| 2026-09-14 | Karen Soares | Deputy General Counsel & Corporate Secretary | Open Market Disposition | -6,846 | $4.78 |
| 2026-09-14 | Brady Priest | Chief Executive Officer of Home Care | Intent to Sell (Form 144) | -215,291 | $4.64 |
| 2026-09-14 | Jamie Reynoso | Divisional Chief Executive Officer of Medicare Advantage | Open Market Disposition | -9,273 | $4.78 |
| 2026-09-14 | Conrad Wai | Chief Technology Officer | Automatic Disposition | -300,000 | $4.72 |
| 2026-09-13 | Joseph Oldakowski | VP of Finance & Controller | Open Market Disposition | -20,000 | $5.16 |
| 2026-08-30 | Brady Priest | Chief Executive Officer of Home Care | Intent to Sell (Form 144) | -73,516 | $4.15 |
| 2026-08-16 | Clay Thornton | Chief Financial Officer of Medicare Advantage Division | Open Market Disposition | -17,775 | $4.39 |
| 2026-08-13 | Brady Priest | Chief Executive Officer of Home Care | Intent to Sell (Form 144) | -474,801 | $4.57 |
| 2026-08-11 | Karen Soares | Deputy General Counsel & Corporate Secretary | Other Acquisition | +108,695 | -- |
| 2026-08-11 | Clay Thornton | Chief Financial Officer of Medicare Advantage Division | Other Acquisition | +54,347 | -- |
| 2026-08-09 | Andrew Toy | Chief Executive Officer | Open Market Disposition | -87,798 | $4.65 |
| 2026-08-06 | Brady Priest | Chief Executive Officer of Home Care | Intent to Sell (Form 144) | -441,601 | $4.85 |
Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:50:58 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
Clover 医疗 讨论区 0 条评论